266 Virtual Screening of Anticancer Drugs
Gane, P.J. and Dean, P.M. (2000) Recent advances in structure-based rational drug design. Current
Opinion in Structural Biology 10, 401–404.
Klebe, G. (2000). Recent developments in structure-based drug design. Journal of Molecular
Medicine (Berlin) 78, 269–281.
Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S.J. and Fujiki H.
(1993). Anticarcinogenic activity of green tea polyphenols. Japanese Journal of Clinical
Oncology 23(3), 186-90.
Liang, Y.C., Lin-Shiau, S.Y., Chen, C.F. and Lin J.K. (1997) Suppression of extracellular signals and
cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431
epidermoid carcinoma cells. Journal of Cellular Biochemistry 67, 55-65.
Lipinski, C.A., Lombardo, F. and Dominy, B.W. (2000) Drug-like properties and the causes of poor
solubility and poor permeability. Journal of Pharmacological and Toxicological Methods 44,
235–249.
Lipinski, C.A. et al. (1997) Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23,
3–25.
Martelli, A.M., Bortul, R., Bareggi, R., Takelloni, G., Grill, V., Baldini, G. and Narducci, P. (1999)
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol
production in the nucleus of HL-60 human promyelocytic leukemia cells. Cancer Research 59,
3961–3967.
Matsumoto, Y., Gujiwara, T. and Nago, S. (1995) Determinants of drug response in camptothecin-
resistant glioma cell lines. Journal of Neurooncology 23, 1–8.
Nieves-Neira, W. and Pommier, Y. (1999) Apoptotic response to camptothecin and 7-hydroxy-
staurosporine (UCN-01) in the eight human breast cell lines of the NCI anticancer drug screen:
Multifactorial relationships with topoisomerase 1, protein kinase C, Bcl-2, p53, MDM-2 and
caspase pathway. International Journal of Cancer 82, 396–404.
Shoichet, B.K., McGovern, S.L., Wei, B. and Irwin, J.J. (2002) Lead discovery using molecular
docking. Current Opinion in Chemical Biology 6, 439–446.
Sinha, B.K. (1995) Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs
49, 11–19.
Subramaniam, S., Mehrotra, M. and Gupta, D. (2008) Virtual high throughput screening (VHTS) – A
perspective. Bioinformation 3(1), 14–17.
Veber, D.F., Johnson, S.R., Cheng, H.Y., Smith, B.R., Ward, K.W. and Kopple, K.D. (2002)
Molecular properties that influence the oral bioavailability of drug candidates. Journal of
Medicinal Chemistry 45, 2615–2623.
Walters, W.P., Stahl, M.T. and Murcko, M.A. (1998) Virtual screening– an overview. Drug
Discovery Today 3, 160–178.
Wang, M.C., Liu, J.H. and Wang, F.F. (1997) Protein tyrosine phosphatase-dependent activation of
-globin and -aminolevulenic acid synthase genes in the camptothecin-induced IW 32
erythroleukemia cell differentiation. Molecular Pharmacology
51, 558–566.